UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 4, 2013
CORONADO BIOSCIENCES, INC.
(Exact Name of Registrant as Specified in Charter)
| | | | |
| Delaware | | 001-35366 | | 20-5157386 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
| | |
| 24 New England Executive Park, Burlington, MA | | 01803 |
| (Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s Telephone Number, Including Area Code: (781) 652-4500
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
On June 4, 2013, Coronado Biosciences, Inc. (the “Company”) issued a press release announcing that George Avgerinos, Ph.D. has joined the Company as Senior Vice President, Biologics Operations. Dr. Avgerinos will lead the Company’s global manufacturing and supply chain efforts for both TSO (Trichuris suis ova or CNDO-201) and CNDO-109, including the development of the Company’s manufacturing facility for TSO in Woburn, Massachusetts. A copy of this press release is attached as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
| | |
Exhibit
No. | | Description |
| |
| 99.1 | | Press release issued June 4, 2013. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | |
| | | | CORONADO BIOSCIENCES, INC. |
| | |
| Date: June 4, 2013 | | | | /s/ Dale Ritter |
| | | | Name: | | Dale Ritter |
| | | | Title: | | Senior Vice President, Finance |
